Europe - BIT:1ANTM - US0367521038 - Common Stock
The current stock price of 1ANTM.MI is 304.2 EUR.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| UNH.DE | UNITEDHEALTH GROUP INC | 14.38 | 283.16B | ||
| 1UNH.MI | UNITEDHEALTH GROUP INC | 14.37 | 282.93B | ||
| A58.DE | ELEVANCE HEALTH INC | 11.19 | 66.56B | ||
| 1CNC.MI | CENTENE CORP | 6.92 | 15.09B |
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The company is headquartered in Indianapolis, Indiana and currently employs 103,158 full-time employees. The company went IPO on 2001-10-30. The company operates as a health insurer in the United States. The firm operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.
ELEVANCE HEALTH INC
220 Virginia Avenue
Indianapolis INDIANA US
Employees: 103158
Phone: 18003311476
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The company is headquartered in Indianapolis, Indiana and currently employs 103,158 full-time employees. The company went IPO on 2001-10-30. The company operates as a health insurer in the United States. The firm operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.
The current stock price of 1ANTM.MI is 304.2 EUR. The price increased by 0.9% in the last trading session.
ELEVANCE HEALTH INC (1ANTM.MI) has a dividend yield of 1.96%. The yearly dividend amount is currently 5.61.
1ANTM.MI has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
1ANTM.MI stock is listed on the Euronext Milan exchange.
ELEVANCE HEALTH INC (1ANTM.MI) operates in the Health Care sector and the Health Care Providers & Services industry.
The Revenue of ELEVANCE HEALTH INC (1ANTM.MI) is expected to grow by 12.33% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
ChartMill assigns a technical rating of 3 / 10 to 1ANTM.MI.
ChartMill assigns a fundamental rating of 4 / 10 to 1ANTM.MI. There are concerns on the financial health of 1ANTM.MI while its profitability can be described as average.
Over the last trailing twelve months 1ANTM.MI reported a non-GAAP Earnings per Share(EPS) of 28.27. The EPS decreased by -6.64% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.83% | ||
| ROA | 4.4% | ||
| ROE | 12.26% | ||
| Debt/Equity | 0.65 |
28 analysts have analysed 1ANTM.MI and the average price target is 317.97 EUR. This implies a price increase of 4.53% is expected in the next year compared to the current price of 304.2.
For the next year, analysts expect an EPS growth of -8.43% and a revenue growth 12.33% for 1ANTM.MI